Recent Posts
- Elutia Appoints Accomplished MedTech Veteran Guido J. Neels to Board of Directors
- Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million
- Elutia Announces Newly Published Clinical Data Demonstrating that Biologic Envelopes Support CIED Stabilization and Ease of Reoperation
- Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million
- Elutia Selected to Exhibit EluPro™ Antibiotic Eluting BioEnvelope at Vizient Innovative Technology Exchange